KLRA
Kailera Therapeutics, Inc. • NASDAQ
$22.94 ▲ 0.00% (+0.00)
KLRA
Kailera Therapeutics, Inc.NASDAQ • $22.94 ▲ 0.00% (+0.00)
Market Cap $2.97 B
52w High $28.23
52w Low $19.01
P/E -12.89
Volume 555.94K
Outstanding Shares 129.57M
Market Cap $2.97 B
52w High $28.23
52w Low $19.01
P/E -12.89
Volume 555.94K
Outstanding Shares 129.57M
About Kailera Therapeutics, Inc.
www.kailera.comKailera Therapeutics is a clinical-stage biopharmaceutical company developing a diverse pipeline of next-generation therapies designed to treat obesity and related conditions.
CEO
Ronald C. Renaud Jr.
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Biotechnology
Sector Healthcare
Went public April 17, 2026
Method of going public IPO
Full time employees 145
AUG
25 TUE
Upcoming Earnings
Date Aug 25, 2026
Day Tuesday
Revenue Est. —
ETFs Holding This Stock
Summary
Total 21
Showing Top 3 of 21
Price Target
Target High $48
Target Low $36
Target Median $42
Target Consensus $42